Elite Pharmaceuticals Inc (ELTP)

[lasers]

Hydromorphone 10-Q Comments

http://www.sec.gov/Archives/edgar/data/1053369/000114420412008039/v301334_10q.htm


Approval of Hydromorphone 8mg

On January 23, 2012, the Company received notice from the FDA that the FDA approved the Company’s supplemental application for the manufacturing and packaging of Hydromorphone Hydrochloride USP 8mg. This approval will allow the Company to commence the commercial manufacturing and packaging of this product for its sales and marketing partner, Precision Dose Inc. and its wholly owned subsidiary, TAGI Pharmaceuticals Inc., which will distribute the product as part of a multi-product distribution agreement.

If there were a 3rd party manufacturing partner Elite would have been under SEC legal obligation to have stated the details. There is no such statement. Elite has clearly stated details of their sales and marketing partner.


This approval will allow the Company to commence the commercial manufacturing and packaging of this product for its sales and marketing partner, Precision Dose Inc. and its wholly owned subsidiary, TAGI Pharmaceuticals Inc., which will distribute the product as part of a multi-product distribution agreement.

If there were a 3rd party manufacturing partner Elite would have been under SEC legal obligation to have stated the details. There is no such statement!